Frequency Therapeutics — Hearing Loss Regeneration

Having REGAIN, Frequency Therapeutics and Otonomy all working on cures are a lot more options than we had just a few years ago. I personally did the LLLT for 2 years. Although it calmed down my tinnitus, it never helped me regain my hearing loss. I'm keeping my eye on these 3.
 
Having REGAIN, Frequency Therapeutics and Otonomy all working on cures are a lot more options than we had just a few years ago. I personally did the LLLT for 2 years. Although it calmed down my tinnitus, it never helped me regain my hearing loss. I'm keeping my eye on these 3.
Fun fact: there are 43 companies currently working on hearing restoration drugs right now :)
 
Better slow than nothing.... And I really hope for a breakthrough! I want to be able to hear!
I just would think that considering how many vets there are with tinnitus/hearing loss that the ATA would be working with the government to pour a lot of money into this instead of treating it like any other pharma company making any other drug. Considering that the ATA's head, LaGuinn Sherlock, was a research audiologist with the U.S. Army Public Health Center you'd think something like that would be happening.
 
If we do get rid of our tinnitus by having our hair cells regenerated, would our ears still be sensitive to certain sounds e.g., blenders, vacuuming, travelling on planes etc.?
 
My opinion is that, in terms of practical treatment we should mostly keep our eyes on Regain. They are moving much faster than Frequency. They will be done with phase 2 by the end of the year, that's a massive progress. So our best bet to having a cure in a year or two is Regain. Forget Frequency, they're a toast if Regain proves to have have a functioning cure in the Phase 2.
 
LaGuinn Sherlock believes everyone will habituate and there's no need for drug treatments.
I see what you mean. Sounds like a wasted position and money. Our goal is to habituate! We pray for researchers to find a cure!

'Dr. Sherlock works at Walter Reed National Military Medical Center for the US Army Hearing Program as a research audiologist. Her current research interests include the effects of tinnitus on concentration, the efficacy of tinnitus treatment programs, and the evaluation and management of hyperacusis.'
 
My opinion is that, in terms of practical treatment we should mostly keep our eyes on Regain. They are moving much faster than Frequency. They will be done with phase 2 by the end of the year, that's a massive progress. So our best bet to having a cure in a year or two is Regain. Forget Frequency, they're a toast if Regain proves to have have a functioning cure in the Phase 2.
You are assuming both will provide equal results. The literature suggests FX3-22 "cocktail" of small molecules will produce better results than REGAIN's sole use of just a gamma secretase inhibitor.

How this translates in vivo for humans we don't know yet, but I think your conclusion that FX-322 is toast is a bit presumptuous, at this point in time, if they don't reach the finish line first.
 
You are assuming both will provide equal results. The literature suggests FX3-22 "cocktail" of small molecules will produce better results than REGAIN's sole use of just a gamma secretase inhibitor.

How this translates in vivo for humans we don't know yet, but I think your conclusion that FX-322 is toast is a bit presumptuous, at this point in time, if they don't reach the finish line first.
Well, I think that we have to wait and see... I am optimistic about both of them, but especially so about FX-322. Don't ask why, but it sounds bit better... ;-) but hey, the more research we have, the better it is, or? BTW: Cocktails are nice ;-)
 
You are assuming both will provide equal results. The literature suggests FX3-22 "cocktail" of small molecules will produce better results than REGAIN's sole use of just a gamma secretase inhibitor.

How this translates in vivo for humans we don't know yet, but I think your conclusion that FX-322 is toast is a bit presumptuous, at this point in time, if they don't reach the finish line first.
I don't care, no matter what kind of improvement, everyone will throw their money at REGAIN if they release their treatment first, even if it doesn't recover hearing fully but only partially. Those lame asses at Frequency Therapeutics will make $0 if they keep with this pace of progress.
 
You are assuming both will provide equal results. The literature suggests FX3-22 "cocktail" of small molecules will produce better results than REGAIN's sole use of just a gamma secretase inhibitor.

How this translates in vivo for humans we don't know yet, but I think your conclusion that FX-322 is toast is a bit presumptuous, at this point in time, if they don't reach the finish line first.
Well, as far as I have understood, Frequency Therapeutics had only patients with massive hearing loss in their trial, whereas REGAIN tested their drug in people with mild to moderate hearing loss. That's a difference of the research/treatment... Or do I interpret it wrong?
 
Someone posted this on Reddit:

I worked on this clinical trial!! This makes me so happy to see the excitement. I don't really know how much I can say as far as results/patient testimony, but it was the best study I have ever worked on. So rewarding and a great great company!

What is the likelihood that they will mention that this drug actually reduced or cured their tinnitus at the September event?
 
Well, as far as I have understood, Frequency Therapeutics had only patients with massive hearing loss in their trial, whereas REGAIN tested their drug in people with mild to moderate hearing loss. That's a difference of the research/treatment... Or do I interpret it wrong?
Just did some research and you're right. I really hope these companies actually do really well in Phase 2 and 3 and they actually do work in curing tinnitus or reducing it a lot. I don't want this to be another AM-101.
 
 

Attachments

  • Screenshot 2019-05-23 at 14.42.12.png
    Screenshot 2019-05-23 at 14.42.12.png
    153.8 KB · Views: 94
Someone posted this on Reddit:

I worked on this clinical trial!! This makes me so happy to see the excitement. I don't really know how much I can say as far as results/patient testimony, but it was the best study I have ever worked on. So rewarding and a great great company!

What is the likelihood that they will mention that this drug actually reduced or cured their tinnitus at the September event?
I love hearing this!
 

Log in or register to get the full forum benefits!

Register

Register on Tinnitus Talk for free!

Register Now